THRX - Theseus Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

THRX is currently covered by 4 analysts with an average price target of $13.06. This is a potential upside of $9 (221.67%) from yesterday's end of day stock price of $4.06.

Theseus Pharmaceuticals's activity chart (see below) currently has 1 price targets and 15 ratings on display. The stock rating distribution of THRX is 85.71% BUY and 14.29% HOLD.

Stock Analyst Price Targets - Review

Highest price target for THRX is $9, Lowest price target is $7, average price target is $13.06.

Most recent stock forecast was given by ALETHIA YOUNG from CANTOR FITZGERALD on 14-Jul-2023. First documented stock forecast 01-Nov-2021.

Currently out of the existing stock ratings of THRX, 12 are a BUY (85.71%), 2 are a HOLD (14.29%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

7

$2.95 (72.84%)

25

9 months 16 days ago

0/2 (0%)

$4.34 (163.16%)

Hold

23

9 months 17 days ago

0/5 (0%)

$15.26 (197.16%)

Buy

9

$4.94 (121.67%)

22

9 months 17 days ago

0/5 (0%)

$6.34 (238.35%)

Buy

7

$2.94 (72.41%)

24

9 months 17 days ago

0/2 (0%)

$4.34 (163.16%)

Hold

24

11 months 8 days ago

0/1 (0%)

$16.2 (207.69%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is THRX (Theseus Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on THRX (Theseus Pharmaceuticals) with a proven track record?

AMI FADIA

Which analyst has the current lower performing score on THRX (Theseus Pharmaceuticals) with a proven track record?

MAURY RAYCROFT

Which analyst has the most public recommendations on THRX (Theseus Pharmaceuticals)?

Ami Fadia works at NEEDHAM and has 7 price targets and 4 ratings on THRX

Which analyst is the currently most bullish on THRX (Theseus Pharmaceuticals)?

Andrew Berens with highest potential upside - $23.95

Which analyst is the currently most reserved on THRX (Theseus Pharmaceuticals)?

Ami Fadia with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?